Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Cook

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Cellular Signalling|January 16, 2010
Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIMCeri M Wiggins, Mark Johnson, Simon J Cook
Biochemical Society Transactions|January 21, 2012
ERK5 and its role in tumour developmentPamela A Lochhead, Rebecca Gilley, Simon J Cook
Plos One|September 21, 2017
ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell deathNicola J Darling, Kathryn Balmanno, Simon J Cook
Cellular Signalling|March 3, 2009
ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-FosRebecca Gilley, H Nikki March, Simon J Cook
The Biochemical Journal|June 19, 2002
Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1Matthew S Squires, Paula M Nixon, Simon J Cook
The Journal of Biological Chemistry|February 25, 2005
Identification of a DEF-type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimELRebecca Ley, Kathryn Hadfield, Elizabeth Howes, et al.
Molecular and Cellular Biology|December 4, 2003
DeltaRaf-1:ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentryKathryn Balmanno, Tracy Millar, Martin McMahon, et al.
The Biochemical Journal|July 16, 2021
Inhibitory feedback control of NF-κB signalling in health and diseaseJack A Prescott, Jennifer P Mitchell, Simon J Cook
Biochemical Society Transactions|September 11, 2020
Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: be careful what you wish for…Simon J Cook, Julie A Tucker, Pamela A Lochhead
Oncogene|July 25, 2003
Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibitedSarah A Molton, Daniel E Todd, Simon J Cook
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Cellular Signalling|January 16, 2010
Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIMCeri M Wiggins, Mark Johnson, Simon J Cook
Biochemical Society Transactions|January 21, 2012
ERK5 and its role in tumour developmentPamela A Lochhead, Rebecca Gilley, Simon J Cook
Plos One|September 21, 2017
ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell deathNicola J Darling, Kathryn Balmanno, Simon J Cook
Cellular Signalling|March 3, 2009
ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-FosRebecca Gilley, H Nikki March, Simon J Cook
The Biochemical Journal|June 19, 2002
Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1Matthew S Squires, Paula M Nixon, Simon J Cook
The Journal of Biological Chemistry|February 25, 2005
Identification of a DEF-type docking domain for extracellular signal-regulated kinases 1/2 that directs phosphorylation and turnover of the BH3-only protein BimELRebecca Ley, Kathryn Hadfield, Elizabeth Howes, et al.
Molecular and Cellular Biology|December 4, 2003
DeltaRaf-1:ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentryKathryn Balmanno, Tracy Millar, Martin McMahon, et al.
The Biochemical Journal|July 16, 2021
Inhibitory feedback control of NF-κB signalling in health and diseaseJack A Prescott, Jennifer P Mitchell, Simon J Cook
Biochemical Society Transactions|September 11, 2020
Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: be careful what you wish for…Simon J Cook, Julie A Tucker, Pamela A Lochhead
Oncogene|July 25, 2003
Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibitedSarah A Molton, Daniel E Todd, Simon J Cook
Pageof 10